- The acquisition of the Arizona-based microarray solutions company extends SCHOTT’s manufacturing presence in the United States and strengthens its bioscience capabilities.
- Customers will benefit from enhanced development and manufacturing capabilities including high-density microarray printing.
The University of Arizona James E. Rogers College of Law and AZBio have joined forces to offer a 10% tuition discount to AZBio members for all online degrees and programs offered at the college.Continue reading
The funding round bolsters Tesis Labs’ capacity to meet the growing customer demand and clinical research initiativesContinue reading
Arizona’s FAST program funds resources, training and network opportunities to aid entrepreneurs in their SBIR proposal success. Grants will be distributed in three rounds from October 2021 to September 2022. Each round will award six applicants up to $3,000 each.
Francis S. Collins, M.D., Ph.D., today announced his decision to end his tenure as the director of the National Institutes of Health by the end of the year. Dr. Collins is the longest serving presidentially appointed NIH director, having served three U.S. presidents over more than 12 years.Continue reading
Veteran Drug Developer Stephen Barat, Ph.D. Joins to Head Company’s Therapeutics DivisionContinue reading
Tucson, AZ – based SynCardia is the only company in the world with a US FDA-approved temporary Total Artificial Heart (TAH). It is also CE marked in Europe and approved for use in over 30 countries around the world. The SynCardia TAH has been saving and extending lives in Europe and North America, having been implanted over 2,000 times to-date and it has accumulated hundreds of years of proven patient use and safety data.Continue reading
The network, established with funding from the National Institutes of Health, has the the ultimate goal of developing more effective brain-aging treatments and interventions targeted to the individual.